EGF-IL2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models

The epidermal growth factor receptor (EGFR) remains one of the best molecules for developing targeted therapy for multiple human malignancies, including head and neck squamous cell carcinoma (HNSCC). Small molecule inhibitors or antibodies targeting EGFR have been extensively developed in recent dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yue, Qi, Zeng, Wang, Zhaohui, Cao, Yu, Lu, Ling, Zhang, Huiping, Mathes, David, Pomfret, Elizabeth A., Lu, Shi-Long, Wang, Zhirui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827275/
https://www.ncbi.nlm.nih.gov/pubmed/36579667
http://dx.doi.org/10.3892/or.2022.8474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827275/
https://www.ncbi.nlm.nih.gov/pubmed/36579667
http://dx.doi.org/10.3892/or.2022.8474

Ejemplares similares